Is Surrozen Inc. Warrant (SRZNW) overvalued? · rev $10.7M
Surrozen Inc. Warrant (SRZNW) is a biotechnology company listed on US.
This page asks whether Surrozen Inc. Warrant (SRZNW) looks expensive on cached numbers — not a short thesis.
Latest reported SRZNW revenue for 2024-12-31 was $10.7M. Net income was -$63.6M. SRZNW currently screens at market cap $0.
SRZNW currently screens at market cap $0. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next SRZNW 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the SRZNW stock page for the full model, not this heading.
Not investment advice.